Asia petrochemical outlook 2018

| February 15, 2018

article image
While all trade routes in the petrochemical market have in the past led to China, 2018 is the year when these routes could begin to show signs of slow reversal — leading to the rise of China as a dominant Asian exporter in the next decade. China’s move towards self-sufficiency has long been a topic of conference presentations and white papers, and the last months of 2017 gave ample indications that this moment has finally arrived.

Spotlight

Immunocore

Based in Abingdon (UK) and Philadelphia (USA) we're a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Our world-leading T cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells. We've established a robust technology platform which combines monoclonal T cell receptor (mTCR) targeting technology with an effector technology, anti-CD3 scFv, that catalyses the killing of the targeted diseased cells by the host’s own non-specific cytotoxic T cells. And we're developing a portfolio of products from the platform, called ImmTACs, for the treatment of cancer, chronic infectious disease and diabetes.

OTHER ARTICLES

Boom in petrochemicals demand guaranteed but we must grow sustainably

Article | June 3, 2021

ONE OF THE GREATEST achievements of the last 30 years has been the fall in the number of people living in extreme poverty.In 1999, 1.9bn of the world’s population were living on less than $1.90, the Word Bank’s definition of extreme poverty. Despite setbacks caused by the pandemic, this had fallen to 698m by October 2020. Income levels alone are not enough to escape the life-threatening agony of extreme poverty. There is no point in having money if the essential goods and services to spend your money on are not available. Critical to poverty alleviation has been sufficient supply of all the things that people in the rich world take for granted. The raw materials to make the vast majority of manufactured goods include petrochemicals and polymers. Nearly all the major manufacturing chains would not have been able to function without petrochemicals. Think of medical equipment, syringes, blood bags, hospital gowns, face masks, pill bottles and medicine blister packs. None of the above could have been produced without petrochemicals. As people emerged out of extreme poverty and as economies became wealthier, modern-day medical services became more widely available.

Read More

The Potential Dangers Of Living Near A Chemical Plant

Article | February 21, 2020

Plant explosion may feel like a familiar news headline to Texans. But why? It's not the case in other areas of the country. Why do explosions seem so prevalent here? A straightforward reason for the unusual number of explosions in Texas is the type of industries that drive its economy. Texas is the nation's leader when it comes to petroleum refining and chemical product production. Refineries and production plants handle volatile chemicals. Without proper monitoring and safety measures, dangerous explosions can result.

Read More

Guyana-Suriname basin: Rise from obscurity to super potential

Article | May 13, 2021

Recent discoveries in the Guyana-Suriname basin attest to estimates of 10+ Bbbl of oil resources and more than 30 Tcf of gas.1 Like many oil & gas successes, this is a story that begins with early exploration success onshore, followed by a long period of exploration disappointment in coastal to shelf regions offshore, eventually culminating in deepwater success.

Read More

Demographics are reshaping petrochemicals trade flows, investment patterns and demand

Article | May 23, 2021

TEN YEARS AGO, fellowblogger Paul Hodgesand Ifirst highlighted the leading rolethat changing demographics would play in reshaping petrochemicals supply and demand. We have been emphasising the importance of demographics ever since. Demographics have, of course, always been a critical shaper of economies throughout human history. But during the last 70 years, there have been such major changes in demographics that the study of demographics must be at the very heart of your company’s strategy. The Babyboomer generation in the West led to a surge in demand as the rapid increase in babies born in the 1950s and early 1960s joined the workforce from the 1970s onwards. This helps explain high levels of inflation during that decade because too much demand was chasing too little supply. Another driver of inflation was the Middle East embargos against oil exports to the West because of the West’s support for Israel. Then came the 1990s and first the integration of Eastern Europe into the global economy. This helped dampen inflationary pressures because of the plentiful supply of workers in the east willing to work for low wages in export-focused factories. This reduced the cost of finished goods in the West. Next came Deng Xiaoping’s critically important“southern tour”in the early 1990s and China’s gradual integration into the global economy. China increasingly leveraged its very youthful population to again make cheap goods to export to the West. Hundreds of millions of young people were willing to migrate from the countryside to China’s coastal cities to work in export-focused manufacturing plants. The world began to talk about the “China price” and how it was further depressing global inflation.

Read More

Spotlight

Immunocore

Based in Abingdon (UK) and Philadelphia (USA) we're a privately owned biotechnology company developing innovative biological therapeutics for the treatment of a range of serious diseases. Our world-leading T cell receptor technology exploits the power of the body’s own immune system to find and kill diseased cells. We've established a robust technology platform which combines monoclonal T cell receptor (mTCR) targeting technology with an effector technology, anti-CD3 scFv, that catalyses the killing of the targeted diseased cells by the host’s own non-specific cytotoxic T cells. And we're developing a portfolio of products from the platform, called ImmTACs, for the treatment of cancer, chronic infectious disease and diabetes.

Events